rss
Heart 100:862-866 doi:10.1136/heartjnl-2013-304893
  • Cardiac risk factors and prevention
  • Original article

Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA)

  1. 1Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA
  2. 2Department of Biostatistics, Joseph P. Mailman School of Public Health, Columbia University, New York, New York, USA
  3. 3Departments of Medicine and Pathology, University of Vermont College of Medicine, Burlington, Vermont, USA
  4. 4Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
  5. 5Biostatistics Unit, Group Health Research Institute and Department of Biostatistics, University of Washington, Seattle, Washington, USA
  1. Correspondence to Dr Shepard D Weiner, Division of Cardiology, Columbia University College of Physicians and Surgeons, Columbia University Medical Center, New York Presbyterian Hospital, Milstein Family Heart Center, 4th Floor, 173 Fort Washington Avenue, New York, NY 10032, USA; sw2150{at}columbia.edu
  • Received 29 August 2013
  • Revised 6 March 2014
  • Accepted 17 March 2014
  • Published Online First 8 April 2014

Abstract

Background and objective Inflammation and endothelial dysfunction have been implicated in the pathogenesis of atherosclerotic vascular disease. Brachial artery flow-mediated dilation (FMD) is a reliable, non-invasive method of assessing endothelial function. We hypothesised that increased levels of systemic inflammatory markers are associated with impaired endothelial function as assessed by FMD in a multi-ethnic cohort.

Methods We assessed brachial artery FMD in 3501 participants (1739 men, 1762 women; median age 61 years) in the Multi-Ethnic Study of Atherosclerosis and measured serum concentrations of interleukin (IL)-6, C reactive protein (CRP) and tumour necrosis factor (TNF)-α receptor 1. Spearman correlation coefficients were used to evaluate the association of each inflammatory marker with FMD, adjusting for the effect of other variables associated with FMD.

Results There was a significant inverse correlation between IL-6 levels and FMD (−0.042; p=0.02) after adjustment for age, gender, race/ethnicity, education, income, low-density lipoprotein, diabetes, glucose, hypertension status and treatment, waist circumference, triglycerides, baseline brachial diameter, recent infection and use of medications that may alter inflammation. There was no significant correlation between CRP and FMD (0.008; p=0.64) or TNF-α receptor 1 and FMD (0.014; p=0.57). There was no evidence of effect modification by race/ethnicity.

Conclusions In this multi-ethnic cohort, increased levels of the pro-inflammatory cytokine IL-6 were associated with impaired endothelial function assessed by FMD. Elevated IL-6 levels may reflect a state that promotes vascular inflammation and development of subclinical atherosclerosis independent of traditional cardiovascular risk factors.

Responses to this article